Cargando…

Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves’ Disease From Autoimmune Thyroiditis

OBJECTIVE: Graves’ disease (GD) and autoimmune thyroiditis (AIT) are two major causes of thyrotoxicosis that require correct diagnosis to plan appropriate treatment. The objectives of this study were to evaluate the usefulness of thyroid-related parameters for distinguishing GD from AIT and identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhiyong, Zhu, Yu, Zhang, Min, Wang, Chen, Zhou, Lingli, Liu, Wei, Yang, Wenjia, Li, Meng, Zhang, Simin, Ren, Qian, Han, Xueyao, Ji, Linong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821852/
https://www.ncbi.nlm.nih.gov/pubmed/33488527
http://dx.doi.org/10.3389/fendo.2020.620407
_version_ 1783639512523472896
author Wu, Zhiyong
Zhu, Yu
Zhang, Min
Wang, Chen
Zhou, Lingli
Liu, Wei
Yang, Wenjia
Li, Meng
Zhang, Simin
Ren, Qian
Han, Xueyao
Ji, Linong
author_facet Wu, Zhiyong
Zhu, Yu
Zhang, Min
Wang, Chen
Zhou, Lingli
Liu, Wei
Yang, Wenjia
Li, Meng
Zhang, Simin
Ren, Qian
Han, Xueyao
Ji, Linong
author_sort Wu, Zhiyong
collection PubMed
description OBJECTIVE: Graves’ disease (GD) and autoimmune thyroiditis (AIT) are two major causes of thyrotoxicosis that require correct diagnosis to plan appropriate treatment. The objectives of this study were to evaluate the usefulness of thyroid-related parameters for distinguishing GD from AIT and identify a novel index for differential diagnosis of thyrotoxicosis. DESIGN: This retrospective study was performed using electronic medical records in Peking University People’s Hospital (Beijing, China). METHODS: In total, 650 patients with GD and 155 patients with AIT from December 2015 to October 2019 were included in cohort 1. Furthermore, 133 patients with GD and 14 patients with AIT from December 2019 to August 2020 were included in cohort 2 for validation of the novel index identified in cohort 1. All patients were of Chinese ethnicity and were newly diagnosed with either GD or AIT. Thyroid-related clinical information was collected before intervention by reviewing the patients’ electronic medical records. Receiver operating characteristic curve analysis was used to identify the optimal cutoff for distinguishing GD from AIT. RESULTS: In cohort 1, thyroid-stimulating hormone (TSH) receptor antibody was identified as the best indicator for distinguishing GD from AIT. The area under the receiver operating characteristic curve was 0.99(95% confidence interval: 0.98–0.99, p<0.0001)and the optimal cutoff was 0.84 IU/l (98% sensitivity and 99% specificity). The free triiodothyronine (FT3)/TSH ratio (FT3/TSH) was the second –best for distinguishing GD from AIT, the area under the receiver operating characteristic curve of FT3/TSH was 0.86 (95% confidence interval: 0.84–0.88, p<0.0001); its optimal cutoff was 1.99 pmol/mIU (79% sensitivity and 80% specificity). Its effectiveness was confirmed in cohort 2 (81% sensitivity and 100% specificity). CONCLUSIONS: The FT3/TSH ratio is a new useful index for differential diagnosis of thyrotoxicosis, especially when combined with TRAb.
format Online
Article
Text
id pubmed-7821852
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78218522021-01-23 Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves’ Disease From Autoimmune Thyroiditis Wu, Zhiyong Zhu, Yu Zhang, Min Wang, Chen Zhou, Lingli Liu, Wei Yang, Wenjia Li, Meng Zhang, Simin Ren, Qian Han, Xueyao Ji, Linong Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: Graves’ disease (GD) and autoimmune thyroiditis (AIT) are two major causes of thyrotoxicosis that require correct diagnosis to plan appropriate treatment. The objectives of this study were to evaluate the usefulness of thyroid-related parameters for distinguishing GD from AIT and identify a novel index for differential diagnosis of thyrotoxicosis. DESIGN: This retrospective study was performed using electronic medical records in Peking University People’s Hospital (Beijing, China). METHODS: In total, 650 patients with GD and 155 patients with AIT from December 2015 to October 2019 were included in cohort 1. Furthermore, 133 patients with GD and 14 patients with AIT from December 2019 to August 2020 were included in cohort 2 for validation of the novel index identified in cohort 1. All patients were of Chinese ethnicity and were newly diagnosed with either GD or AIT. Thyroid-related clinical information was collected before intervention by reviewing the patients’ electronic medical records. Receiver operating characteristic curve analysis was used to identify the optimal cutoff for distinguishing GD from AIT. RESULTS: In cohort 1, thyroid-stimulating hormone (TSH) receptor antibody was identified as the best indicator for distinguishing GD from AIT. The area under the receiver operating characteristic curve was 0.99(95% confidence interval: 0.98–0.99, p<0.0001)and the optimal cutoff was 0.84 IU/l (98% sensitivity and 99% specificity). The free triiodothyronine (FT3)/TSH ratio (FT3/TSH) was the second –best for distinguishing GD from AIT, the area under the receiver operating characteristic curve of FT3/TSH was 0.86 (95% confidence interval: 0.84–0.88, p<0.0001); its optimal cutoff was 1.99 pmol/mIU (79% sensitivity and 80% specificity). Its effectiveness was confirmed in cohort 2 (81% sensitivity and 100% specificity). CONCLUSIONS: The FT3/TSH ratio is a new useful index for differential diagnosis of thyrotoxicosis, especially when combined with TRAb. Frontiers Media S.A. 2021-01-08 /pmc/articles/PMC7821852/ /pubmed/33488527 http://dx.doi.org/10.3389/fendo.2020.620407 Text en Copyright © 2021 Wu, Zhu, Zhang, Wang, Zhou, Liu, Yang, Li, Zhang, Ren, Han and Ji http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Wu, Zhiyong
Zhu, Yu
Zhang, Min
Wang, Chen
Zhou, Lingli
Liu, Wei
Yang, Wenjia
Li, Meng
Zhang, Simin
Ren, Qian
Han, Xueyao
Ji, Linong
Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves’ Disease From Autoimmune Thyroiditis
title Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves’ Disease From Autoimmune Thyroiditis
title_full Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves’ Disease From Autoimmune Thyroiditis
title_fullStr Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves’ Disease From Autoimmune Thyroiditis
title_full_unstemmed Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves’ Disease From Autoimmune Thyroiditis
title_short Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves’ Disease From Autoimmune Thyroiditis
title_sort serum ratio of free triiodothyronine to thyroid-stimulating hormone: a novel index for distinguishing graves’ disease from autoimmune thyroiditis
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821852/
https://www.ncbi.nlm.nih.gov/pubmed/33488527
http://dx.doi.org/10.3389/fendo.2020.620407
work_keys_str_mv AT wuzhiyong serumratiooffreetriiodothyroninetothyroidstimulatinghormoneanovelindexfordistinguishinggravesdiseasefromautoimmunethyroiditis
AT zhuyu serumratiooffreetriiodothyroninetothyroidstimulatinghormoneanovelindexfordistinguishinggravesdiseasefromautoimmunethyroiditis
AT zhangmin serumratiooffreetriiodothyroninetothyroidstimulatinghormoneanovelindexfordistinguishinggravesdiseasefromautoimmunethyroiditis
AT wangchen serumratiooffreetriiodothyroninetothyroidstimulatinghormoneanovelindexfordistinguishinggravesdiseasefromautoimmunethyroiditis
AT zhoulingli serumratiooffreetriiodothyroninetothyroidstimulatinghormoneanovelindexfordistinguishinggravesdiseasefromautoimmunethyroiditis
AT liuwei serumratiooffreetriiodothyroninetothyroidstimulatinghormoneanovelindexfordistinguishinggravesdiseasefromautoimmunethyroiditis
AT yangwenjia serumratiooffreetriiodothyroninetothyroidstimulatinghormoneanovelindexfordistinguishinggravesdiseasefromautoimmunethyroiditis
AT limeng serumratiooffreetriiodothyroninetothyroidstimulatinghormoneanovelindexfordistinguishinggravesdiseasefromautoimmunethyroiditis
AT zhangsimin serumratiooffreetriiodothyroninetothyroidstimulatinghormoneanovelindexfordistinguishinggravesdiseasefromautoimmunethyroiditis
AT renqian serumratiooffreetriiodothyroninetothyroidstimulatinghormoneanovelindexfordistinguishinggravesdiseasefromautoimmunethyroiditis
AT hanxueyao serumratiooffreetriiodothyroninetothyroidstimulatinghormoneanovelindexfordistinguishinggravesdiseasefromautoimmunethyroiditis
AT jilinong serumratiooffreetriiodothyroninetothyroidstimulatinghormoneanovelindexfordistinguishinggravesdiseasefromautoimmunethyroiditis